You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial
|
|---|---|
| Published in |
Lancet Oncology, August 2016
|
| DOI | 10.1016/s1470-2045(16)30269-8 |
| Pubmed ID | |
| Authors |
Sebastian Stintzing, Dominik P Modest, Lisa Rossius, Markus M Lerch, Ludwig Fischer von Weikersthal, Thomas Decker, Alexander Kiani, Ursula Vehling-Kaiser, Salah-Eddin Al-Batran, Tobias Heintges, Christian Lerchenmüller, Christoph Kahl, Gernot Seipelt, Frank Kullmann, Martina Stauch, Werner Scheithauer, Swantje Held, Clemens Giessen-Jung, Markus Moehler, Andreas Jagenburg, Thomas Kirchner, Andreas Jung, Volker Heinemann, FIRE-3 investigators |
X Demographics
The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 25% |
| Brazil | 1 | 13% |
| Spain | 1 | 13% |
| Unknown | 4 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 4 | 50% |
| Practitioners (doctors, other healthcare professionals) | 2 | 25% |
| Science communicators (journalists, bloggers, editors) | 1 | 13% |
| Scientists | 1 | 13% |
Mendeley readers
The data shown below were compiled from readership statistics for 247 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 2 | <1% |
| United Kingdom | 1 | <1% |
| Uruguay | 1 | <1% |
| Germany | 1 | <1% |
| Unknown | 242 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 44 | 18% |
| Other | 36 | 15% |
| Student > Ph. D. Student | 24 | 10% |
| Student > Master | 23 | 9% |
| Student > Bachelor | 19 | 8% |
| Other | 57 | 23% |
| Unknown | 44 | 18% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 131 | 53% |
| Biochemistry, Genetics and Molecular Biology | 14 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 13 | 5% |
| Agricultural and Biological Sciences | 9 | 4% |
| Nursing and Health Professions | 5 | 2% |
| Other | 23 | 9% |
| Unknown | 52 | 21% |
Attention Score in Context
This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 November 2023.
All research outputs
#1,658,657
of 25,941,588 outputs
Outputs from Lancet Oncology
#1,806
of 6,973 outputs
Outputs of similar age
#28,635
of 351,629 outputs
Outputs of similar age from Lancet Oncology
#37
of 126 outputs
Altmetric has tracked 25,941,588 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,973 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.1. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 351,629 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 126 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.